Semaglutide is a GLP-1 receptor agonist, while Tirzepatide targets both GLP-1 and GIP receptors. Tirzepatide may offer higher weight loss percentages in some patients compared to Semaglutide.

Most patients begin to see weight loss within the first few weeks of starting the program, with significant results typically noticeable within 3-6 months.

Common side effects include gastrointestinal issues such as nausea, vomiting, and diarrhea. Our team will work with you to manage any side effects and adjust your treatment as needed.

No. Semaglutide is not covered by insurance for cosmetic weight loss. For those who are at a higher BMI you may be able to talk with your primary care doctor about options covered under insurance.

Yes, we offer both in-person consultations and the convenience of home delivery for your medication, ensuring you receive it within 1-2 days.